Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

 

Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity
Avatar

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Cell Differentiation Therapies

By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
By Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Leonard Calabrese
241 views
March 24, 2020
0 Comments
Login to view comments. Click here to Login
It Isn’t Just Joint Pain
21:50
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Adverse Events - Immunobiology of CPIs and Autoimmunity: PD-1 Pathwa…

Feat. L. Calabrese
16:28
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Immunologic Basis of Adverse Events: Does Immunosuppression Used for…

Feat. L. Calabrese
09:52
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Prospects of Targeted Therapy for Adverse Events: TNF, IL6, and T Ce…

Feat. L. Calabrese
19:05
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

Rheumatic Immune Related Adverse Events from CPIs: Current and New T…

Feat. C. Calabrese
18:50
Cleveland Clinic's 2020 Management of Checkpoint Inhibitor-Related Toxicity

62 y/o Male With Stage IV Renal Cell Carcinoma: Managing Rheumatic I…

Feat. E. Kirchner, C. Calabrese, L. Calabrese